Stay updated on Pembrolizumab vs Placebo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Placebo in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The history now shows that recruitment is closed ('No longer looking for participants'), and the changes include adding the revision tag v3.6.0 while removing the previous tag v3.5.5.
    Difference
    0.2%
    Check dated 2026-06-15T12:47:03.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A new revision tag, v3.5.5, was added to the history and the previous tag, v3.5.4, was removed, updating the history to reflect the latest site version labeling.
    Difference
    0.1%
    Check dated 2026-06-08T05:33:46.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.5.3 to v3.5.4, reflecting a software version update for the ClinicalTrials.gov record history interface.
    Difference
    0.1%
    Check dated 2026-05-18T03:24:28.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from **v3.5.0** to **v3.5.3**, reflecting a ClinicalTrials.gov site release rather than a change to the trial record details.
    Difference
    0.1%
    Check dated 2026-04-26T09:29:24.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Study status updated to Completed as of 2026-03-17, and recruitment status updated on 2026-02-23 under revision v3.5.0. The previous status 'Active, not recruiting' was removed under revision v3.4.3.
    Difference
    0.4%
    Check dated 2026-03-21T08:44:49.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 is added and the previous revision v3.4.2 is removed. This is a UI/versioning update that does not affect study data or results.
    Difference
    0.1%
    Check dated 2026-03-06T18:26:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Placebo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in NSCLC Clinical Trial page.